AG
VRTX icon

Artal Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Artal Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$22M – 148
2021
Q4 		$22M Sell
100,000
-100,000
-50% -$19.4M 0.6% 44
2021
Q3 		$36.3M Buy
+200,000
New +$39M 0.81% 32
2018
Q2 		– Sell
-100,000
Closed -$16.3M – 118
2018
Q1 		$16.3M Sell
100,000
-100,000
-50% -$16.3M 0.2% 37
2017
Q4 		$30M Buy
+200,000
New +$29.6M 0.45% 19
2017
Q2 		– Sell
-100,000
Closed -$10.9M – 117
2017
Q1 		$10.9M Sell
100,000
-100,000
-50% -$8.8M 0.24% 37
2016
Q4 		$14.7M Buy
+200,000
New +$16.3M 0.33% 28
2016
Q3 		– Sell
-150,000
Closed -$12.9M – 96
2016
Q2 		$12.9M Buy
+150,000
New +$13M 0.27% 29

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return